Ramelteon

Rozerem

Melatonin Receptor Agonist

NADAC/unit $0.7172

No Shortage Tier 1: 16.4% 9 Manufacturers 9 ANDAs

vs. brand Rozerem: Generic saves up to 93% per unit

Covered Lives

Active Shortages

2026-03-19 Product is expected to be available through June 2027., Takeda Pharmaceuticals USA Inc.

2026-03-19 Product is expected to be available through February 2027., Takeda Pharmaceuticals USA Inc.

Generic Manufacturers

ACTAVIS LABORATORIES FL INCANDAS 5 HOLDING LLCAPPCO PHARMA LLCAUROBINDO PHARMA LTDDR REDDYS LABORATORIES SAI3 PHARMACEUTICALS LLCMICRO LABS LTDTAKEDA PHARMACEUTICALS USA INCXIROMED PHARMA ESPANA SLZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Ramelteon drfinder.aiFind doctors who prescribe Ramelteon clinicalrx.aiClinical profile: Ramelteon rxnews.aiLatest news about Ramelteon

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.